| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |